Bluejay Diagnostics (NASDAQ:BJDX) Posts Quarterly Earnings Results

Bluejay Diagnostics (NASDAQ:BJDX) released its quarterly earnings results on Monday. The company reported ($112.37) earnings per share for the quarter, Zacks reports.

Bluejay Diagnostics Stock Performance

Shares of NASDAQ BJDX traded down $0.08 during trading on Monday, hitting $3.73. 13,492 shares of the company were exchanged, compared to its average volume of 191,807. The company has a fifty day moving average price of $3.83 and a 200-day moving average price of $4.52. Bluejay Diagnostics has a 12-month low of $3.03 and a 12-month high of $323.68. The firm has a market capitalization of $2.06 million, a PE ratio of 0.00 and a beta of 0.38.

About Bluejay Diagnostics

Bluejay Diagnostics, Inc, a medical diagnostic company, develops rapid test for the monitoring of disease progression in the United States. It is developing Symphony platform, a technology platform comprising Symphony analyzer that orchestrates blood processing, biomarker isolation, and immunoassay preparation using non-contact centrifugal force; and Symphony Cartridge, which includes reagents and components.